SE437930B - Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition - Google Patents

Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition

Info

Publication number
SE437930B
SE437930B SE7500501A SE7500501A SE437930B SE 437930 B SE437930 B SE 437930B SE 7500501 A SE7500501 A SE 7500501A SE 7500501 A SE7500501 A SE 7500501A SE 437930 B SE437930 B SE 437930B
Authority
SE
Sweden
Prior art keywords
permanent
preparing
procedure
pharmaceutical composition
pharmaceutical
Prior art date
Application number
SE7500501A
Other languages
English (en)
Swedish (sv)
Other versions
SE7500501L (es
Inventor
C J Mcloughlin
R B Himstedt
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of SE7500501L publication Critical patent/SE7500501L/
Publication of SE437930B publication Critical patent/SE437930B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7500501A 1974-01-18 1975-01-17 Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition SE437930B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE7500501L SE7500501L (es) 1975-07-21
SE437930B true SE437930B (sv) 1985-03-25

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500501A SE437930B (sv) 1974-01-18 1975-01-17 Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition

Country Status (18)

Country Link
JP (1) JPS5837284B2 (es)
AT (1) AT349150B (es)
AU (1) AU485660B2 (es)
BE (1) BE824509A (es)
CA (1) CA1040532A (es)
CH (1) CH622947A5 (es)
DE (1) DE2501787A1 (es)
DK (1) DK151770C (es)
ES (1) ES433908A1 (es)
FI (1) FI750113A (es)
FR (1) FR2258177B1 (es)
GB (1) GB1478742A (es)
IE (1) IE40361B1 (es)
IT (1) IT1036072B (es)
LU (1) LU71668A1 (es)
NL (1) NL185130C (es)
SE (1) SE437930B (es)
ZA (1) ZA74385B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PT75550B (en) * 1981-09-22 1984-12-12 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
JPS62502967A (ja) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー 非潰瘍消化不良症の治療
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
ATE81010T1 (de) * 1985-06-13 1992-10-15 Barry James Marshall Zusammensetzungen zur behandlung von magendarmst¯rungen.
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
ATE79261T1 (de) * 1985-06-13 1992-08-15 Barry James M D Marshall Verfahren zur behandlung von magen-darmstoerungen.
EP0363502B1 (de) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Flüssiges, wismuthaltiges Arzneipräparat, Verfahren zum Herstellen desselben und seine Verwendung
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
AU648574B2 (en) * 1990-07-20 1994-04-28 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1288789A (en) * 1968-12-23 1972-09-13 Willem Jacob Serfontein Improved bismuth preparations
DE1900268A1 (de) * 1968-12-23 1969-09-04 Serfontein Willem Jacob Wismuth-Komplex-Praeparat

Also Published As

Publication number Publication date
ES433908A1 (es) 1976-11-16
DE2501787C2 (es) 1987-11-12
FI750113A (es) 1975-07-19
NL185130B (nl) 1989-09-01
AU485660B2 (en) 1977-07-28
JPS5837284B2 (ja) 1983-08-15
CH622947A5 (en) 1981-05-15
GB1478742A (en) 1977-07-06
ATA31875A (de) 1978-08-15
CA1040532A (en) 1978-10-17
DK151770C (da) 1989-11-06
AU7729375A (en) 1976-07-15
FR2258177B1 (es) 1978-07-21
FR2258177A1 (es) 1975-08-18
DK151770B (da) 1988-01-04
IE40361L (en) 1975-07-18
IT1036072B (it) 1979-10-30
SE7500501L (es) 1975-07-21
BE824509A (fr) 1975-07-17
NL185130C (nl) 1990-02-01
DK12675A (es) 1975-09-15
ZA74385B (en) 1975-08-27
AT349150B (de) 1979-03-26
LU71668A1 (es) 1975-06-24
JPS50116623A (es) 1975-09-12
NL7500552A (nl) 1975-07-22
IE40361B1 (en) 1979-05-09
DE2501787A1 (de) 1975-07-24

Similar Documents

Publication Publication Date Title
SE437930B (sv) Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
DK487475A (da) Fremgangsmade til fremstilling af vandkveldende polyalkylenoxid
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
SE7508406L (sv) Forfarande for framstellning av polyfenylenoxid.
IT1042173B (it) Procedimento per preparare butandioli
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
DK292475A (da) Fremgangsmade til fremstilling af derivater af 3-amino-2-hydroxy-1-phenoxy-propan
DK146535C (da) Fremgangsmaade til fremstilling af 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazin-1,1-dioxid-3-carboxamider
DK351875A (da) Fremgangsmade til fremstilling af 7-methoxy-6-thiatetracyliner
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE7507324L (sv) Forfarande for framstellning av slagfasta styrenpolymerisat.
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
DK223175A (da) Fremgangsmade til fremstilling af pyridobenzodiazepinoner
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE400960B (sv) Forfarande for framstellning av alhŸ3 (poŸ4)Ÿ2 3hŸ2o
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE422057B (sv) Forfarande for framstellning av vissa omega-substituerade omega-nor-13,14-dehydro-prostaglandiner
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
DK154890C (da) Fremgangsmaade til fremstilling af 7beta-acylamino-7alfa-alkoxycephalosporiner
SE7504413L (sv) Forfarande for framstellning av en ny antibiotisk substans.
SE7508936L (sv) Forfarande for framstellning av en cinnamamid.
SE421310B (sv) Forfarande for framstellning av substituerade bensoylpyridiner
IT1040067B (it) Procedimento per preparare clorosilani
DK505275A (da) Fremgangsmade til fremstilling af 7,7-diphenylhexahydro-1,4-oxazepiner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500501-7

Effective date: 19940810

Format of ref document f/p: F